Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Psoriasis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01000714
What this trial is testing

Determination of the Efficacy and Safety of Psirelax in the Relief of the Disease in Psoriasis

Who this might be right for
Mild to Moderate Psoriasis
Etwal Ltd.
Post-approval studies (Phase 4)Study completedNCT02412644
What this trial is testing

Apremilast 30mg Bid With Narrowband UVB in the Treatment of Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Psoriasis Treatment Center of Central New Jersey 29
Early research (Phase 1)Study completedNCT02763969
What this trial is testing

Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 357
Not applicableStudy completedNCT05065762
What this trial is testing

Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment

Who this might be right for
Psoriasis
Bristol-Myers Squibb 232
Testing effectiveness (Phase 2)Study completedNCT04207801
What this trial is testing

A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Aurigene Discovery Technologies Limited 90
Early research (Phase 1)UnknownNCT03710681
What this trial is testing

A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Jiangsu HengRui Medicine Co., Ltd. 16
Large-scale testing (Phase 3)WithdrawnNCT01815723
What this trial is testing

Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Forward-Pharma GmbH
Large-scale testing (Phase 3)Study completedNCT04728360
What this trial is testing

Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Bio-Thera Solutions 556
Testing effectiveness (Phase 2)Study completedNCT00687362
What this trial is testing

Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 22
Not applicableStudy completedNCT03757013
What this trial is testing

Assess Benefits of Apremilast in Patients With Moderate to Severe Chronic Plaque Psoriasis Followed by Dermatologists Under Real Life Settings in France

Who this might be right for
Psoriasis
Amgen 453
Testing effectiveness (Phase 2)Study completedNCT01831466
What this trial is testing

Tofacitinib Ointment For Chronic Plaque Psoriasis

Who this might be right for
Psoriasis VulgarisPsoriasis
Pfizer 476
Early research (Phase 1)Study completedNCT01510951
What this trial is testing

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Psoriasis

Who this might be right for
Psoriasis
Amgen 9
Testing effectiveness (Phase 2)Study completedNCT05364554
What this trial is testing

A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 227
Large-scale testing (Phase 3)Study completedNCT00687401
What this trial is testing

Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 215
Testing effectiveness (Phase 2)Ended earlyNCT05655299
What this trial is testing

VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Ventyx Biosciences, Inc 222
Testing effectiveness (Phase 2)Study completedNCT01107457
What this trial is testing

A Study in Participants With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 142
Testing effectiveness (Phase 2)UnknownNCT04117919
What this trial is testing

Psoriasis、Indigo Naturalis、Chinese Medicine Medicated Bath

Who this might be right for
Psoriasis
China Medical University Hospital 30
Large-scale testing (Phase 3)Study completedNCT03897075
What this trial is testing

Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Nail Psoriasis
Sun Pharmaceutical Industries Limited 99
Not applicableUnknownNCT02447068
What this trial is testing

Luma Light System Proof of Concept Study in Subjects With Mild to Moderate Psoriasis

Who this might be right for
Psoriasis
Illumicure Inc 10
Testing effectiveness (Phase 2)Study completedNCT01987843
What this trial is testing

Dose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Tanabe Pharma Corporation 142
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation